PHARMACODYNAMICS AND PHARMACOKINETICS OF CYCLOSPORINE-A IN THE NEWBORN PIG

被引:4
|
作者
TSAO, PW
ITO, S
WONG, PY
RADDE, IC
BRYSON, S
YOUNG, DS
CASPI, J
DIAZ, RJ
MARTELL, MF
AUGUSTINE, JM
WILSON, GJ
COLES, JG
机构
[1] HOSP SICK CHILDREN,DEPT CARDIOVASC RES,DIV CARDIOVASC SURG,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] HOSP SICK CHILDREN,DEPT PATHOL,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA
[3] TORONTO HOSP,DEPT CLIN CHEM,DIV CLIN PHARMACOL,TORONTO,ON,CANADA
[4] UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A1,ONTARIO,CANADA
来源
关键词
CYCLOSPORINE-A PHARMACOKINETICS; NEWBORN PIG; IMMUNOSUPPRESSION; LYMPHOCYTE PROLIFERATION;
D O I
10.1159/000480594
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition kinetics of cyclosporin A in the neonates as well as age-related differences in lymphocyte responses to cyclosporin A are unknown. A single intravenous infusion of cyclosporin A was given to neonatal (2.5 or 5 mg/kg) and mature pigs (10 mg/kg) and blood cyclosporin A levels were measured by RIA. The neonates had longer elimination half-life and lower drug clearance than mature animals. Suppression in lymphocyte proliferation was only observed in mixed lymphocyte reaction and phytohemagglutinin-stimulated cultures of the 2-hour samples from neonates receiving 5 mg/kg. We conclude that neonatal pigs exhibit different cyclosporin A pharmacokinetics and show higher sensitivity to cyclosporin A than mature animals.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [21] THE EFFECTS OF CO-DERGOCRINE ON CYCLOSPORINE A PHARMACOKINETICS AND PHARMACODYNAMICS
    HEINRICHS, DA
    MARTELL, R
    STILLER, CR
    FREEMAN, D
    CARRUTHERS, G
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 24 (01) : 117 - 118
  • [22] PHARMACOKINETICS AND METABOLISM OF CYCLOSPORINE-A IN 19 HEMODIALYSIS-PATIENTS
    KULLINGER, B
    WOLFRAM, J
    HAMILTON, G
    HORZEMSKY, M
    KOVARIK, J
    WOLOSZCZUK, W
    STEINER, G
    [J]. TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1702 - 1705
  • [23] EFFICACY AND PHARMACOKINETICS OF 2 FORMULATIONS OF CYCLOSPORINE-A IN PATIENTS WITH PSORIASIS
    ELDER, CA
    MOORE, M
    CHANG, CT
    JIN, J
    CHARNICK, S
    NEDELMAN, J
    COHEN, A
    GUZZO, C
    LOWE, N
    SIMPSON, K
    KARARA, AH
    MELIGENI, J
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (09): : 865 - 875
  • [24] CYCLOSPORINE-A
    MACIA, JL
    [J]. MEDICINA CLINICA, 1984, 83 (09): : 381 - 391
  • [25] CYCLOSPORINE-A
    FALK, R
    HAMMOND, JE
    [J]. EMERGENCY MEDICINE, 1986, 18 (21) : 103 - &
  • [26] CYCLOSPORINE-A
    PAGE, EH
    WEXLER, DM
    GUENTHER, LC
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (05) : 785 - 791
  • [27] CYCLOSPORINE-A
    REIG, JA
    ROS, JO
    TARRES, MV
    [J]. MEDICINA CLINICA, 1985, 84 (11): : 462 - 463
  • [28] LIPOSOMAL FORMULATIONS OF CYCLOSPORINE-A - INFLUENCE OF LIPID TYPE AND DOSE ON PHARMACOKINETICS
    FAHR, A
    HOLZ, M
    FRICKER, G
    [J]. PHARMACEUTICAL RESEARCH, 1995, 12 (08) : 1189 - 1198
  • [29] PHARMACOKINETICS OF CYCLOSPORINE-A IN RENAL-TRANSPLANT PATIENTS AFTER INFUSION
    GU, CN
    DENG, YL
    ZHU, YH
    ZHU, CJ
    GU, QP
    [J]. ACTA PHARMACOLOGICA SINICA, 1991, 12 (06): : 528 - 530
  • [30] CYCLOSPORINE-A
    GUPTA, AK
    ELLIS, CN
    GOLDFARB, MT
    COOPER, KD
    ROCHER, L
    BROWN, MD
    BAADSGAARD, O
    VOORHEES, JJ
    [J]. CLINICS IN DERMATOLOGY, 1989, 7 (03) : 98 - 110